V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011841 | 240008042 | 1.77 | 91 | Curative (C) | 2015-01-08 | 2015-01-08 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240032572 | NOT MATCHED |
| 240011842 | 240008044 | 1.1 | 95 | Curative (C) | 2015-07-10 | 2015-07-16 | CYCLOPHOSPHAMIDE + DOCETAXEL + DOXORUBICIN | N | N | 240032573 | NOT MATCHED |
| 240011843 | 240008045 | 1.55 | 79.3 | Disease modification (D) | 2013-09-24 | 2013-11-06 | Azacitidine | N | N | 240032578 | AZACITIDINE |
| 240011844 | 240012307 | 1.85 | 107.1 | Curative (C) | 2015-08-26 | 2015-09-13 | INTERLACE TRIAL | N | N | 240032580 | INTERLACE TRIAL |
| 240011845 | 240012308 | 1.67 | 90.2 | Curative (C) | 2013-05-03 | 2013-06-07 | null | 2 | N | 240032580 | NOT MATCHED |
| 240011848 | 240012314 | 1.78 | 111.3 | Palliative (P) | 2017-01-11 | 2017-01-11 | Paclitaxel 7 day | N | null | 240032600 | PACLITAXEL |
| 240011849 | 240012314 | 1.67 | 99 | Curative (C) | null | 2014-01-19 | INTERLACE TRIAL | N | N | 240032600 | INTERLACE TRIAL |
| 240011850 | 240012314 | 1.8 | null | Disease modification (D) | 2018-03-13 | 2018-03-13 | ALCL ALCL 99 Closed BM 1, 2 or 3 | Y | N | 240032600 | NOT MATCHED |
| 240011851 | 240012314 | 1.72 | 98.4 | Curative (C) | null | 2013-07-18 | Trial Unspecified | N | N | 240032600 | TRIAL |
| 240011852 | 240008056 | 1.63 | 94.2 | Palliative (P) | 2018-03-22 | 2018-03-23 | Trial Unspecified | N | N | 240032633 | TRIAL |
| 240011853 | 240008056 | 1.75 | 0 | Palliative (P) | 2015-12-22 | 2015-12-27 | Bevacizumab 15mg/kg | N | N | 240032633 | BEVACIZUMAB |
| 240011854 | 240008057 | null | 60 | null | 2013-03-05 | 2013-07-23 | Trial Unspecified | null | null | 240032634 | TRIAL |
| 240011855 | 240008057 | 1.74 | 94.6 | Palliative (P) | 2013-07-08 | 2013-07-10 | Paclitaxel (2 or 3 weekly) | 02 | N | 240032634 | PACLITAXEL |
| 240011856 | 240015336 | 1.57 | 83.3 | Palliative (P) | 2015-08-12 | 2015-08-20 | Azacitidine | 02 | N | 240032648 | AZACITIDINE |
| 240011857 | 240008059 | 1.72 | 76 | Curative (C) | 2017-06-05 | 2017-06-05 | null | N | N | 240032650 | NOT MATCHED |
| 240011858 | 240008063 | 1.6 | 63.4 | Curative (C) | 2017-12-26 | 2018-01-01 | Trial Unspecified | N | N | 240032656 | TRIAL |
| 240011859 | 240008064 | 1.66 | 46.7 | Curative (C) | 2016-09-04 | 2016-09-06 | INTERLACE TRIAL | 02 | N | 240032660 | INTERLACE TRIAL |
| 240011860 | 240012320 | 0 | 115.9 | Adjuvant (A) | 2014-07-26 | 2014-07-26 | Azacitidine | N | null | 240032660 | AZACITIDINE |
| 240011861 | 240012320 | 1.69 | 92.5 | null | 2016-09-02 | 2016-09-02 | Methotrexate intrathecal | N | N | 240032660 | METHOTREXATE INTRATHECAL |
| 240011862 | 240016260 | 1.68 | 80 | Palliative (P) | 2015-01-03 | 2015-01-03 | PACLITAXEL | N | N | 240032666 | PACLITAXEL |
| 240011863 | 240008065 | null | null | Disease modification (D) | 2018-01-05 | 2018-01-19 | Azacitidine | N | N | 240032690 | AZACITIDINE |
| 240011864 | 240012321 | 1.69 | 94.6 | Curative (C) | 2016-04-07 | 2016-04-21 | Bevacizumab | 01 | N | 240032692 | BEVACIZUMAB |
| 240011865 | 240012321 | 1.61 | 80 | Palliative (P) | null | 2017-06-19 | Paclitaxel 7 day | 2 | N | 240032692 | PACLITAXEL |
| 240011866 | 240008067 | null | 20.3 | Palliative (P) | null | 2014-04-21 | Carboplatin AUC 2 - 5 | N | null | 240032702 | CARBOPLATIN |
| 240011867 | 240008068 | 0 | 44 | null | 2017-04-28 | 2017-07-09 | Azacitidine | N | N | 240032706 | AZACITIDINE |
| 240011868 | 240008068 | 1.63 | null | Palliative (P) | 2018-07-04 | 2018-07-05 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032706 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011869 | 240014325 | 1.7 | 82.7 | null | 2016-09-15 | 2016-09-18 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 2 | N | 240032716 | NOT MATCHED |
| 240011870 | 240014325 | 1.8 | 97 | Curative (C) | 2014-09-26 | 2014-09-30 | Carboplatin AUC 6 - 10 | 02 | N | 240032716 | CARBOPLATIN |
| 240011871 | 240008069 | 1.72 | 72.9 | Disease modification (D) | 2017-08-29 | 2017-08-31 | Azacitidine | N | N | 240032736 | AZACITIDINE |
| 240011872 | 240012323 | 1.47 | 31 | Neo-adjuvant (N) | 2017-12-30 | 2018-01-29 | Trial Unspecified | N | N | 240032757 | TRIAL |
| 240011873 | 240008071 | 1.64 | 92 | Disease modification (D) | 2017-06-18 | 2017-07-11 | Methotrexate intrathecal | 2 | N | 240032757 | METHOTREXATE INTRATHECAL |
| 240011874 | 240008072 | 1.88 | 103 | Palliative (P) | 2017-11-15 | 2017-11-30 | INTERLACE TRIAL | 2 | N | 240032768 | INTERLACE TRIAL |
| 240011875 | 240008073 | 1.84 | 96 | Curative (C) | 2017-08-21 | 2017-08-22 | Paclitaxel 7 day | 01 | N | 240032771 | PACLITAXEL |
| 240011876 | 240008073 | null | 32.2 | Palliative (P) | 2014-01-11 | 2014-01-11 | Trial Unspecified | 02 | N | 240032771 | TRIAL |
| 240011877 | 240012327 | 1.7 | 87.4 | Adjuvant (A) | 2018-04-28 | 2018-06-03 | Methotrexate intrathecal | 02 | N | 240032782 | METHOTREXATE INTRATHECAL |
| 240011878 | 240012327 | 1.8 | 0 | Disease modification (D) | 2017-02-25 | 2017-02-25 | INTERLACE TRIAL | 02 | N | 240032782 | INTERLACE TRIAL |
| 240011879 | 240008076 | 1.65 | 60.8 | Curative (C) | null | 2013-02-24 | Bevacizumab+Carbo+Pacliaxel | N | N | 240032790 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011880 | 240012328 | 1.55 | null | Adjuvant (A) | 2016-02-23 | 2016-03-02 | BEVACIZUMAB + CARBO + PACLITAXEL | null | null | 240032803 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011881 | 240008078 | null | 62.3 | null | 2016-01-27 | 2016-02-01 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 2 | N | 240032809 | NOT MATCHED |
| 240011882 | 240008079 | 1.53 | 64.9 | Curative (C) | 2016-03-29 | 2016-05-25 | INTERLACE TRIAL | 99 | N | 240032821 | INTERLACE TRIAL |
| 240011883 | 240012329 | null | 62.3 | Palliative (P) | 2017-04-12 | 2017-05-02 | AML Relapsed FLA - Idarubicin | N | N | 240032821 | NOT MATCHED |
| 240011884 | 240012329 | 1.69 | 103.6 | Curative (C) | 2017-08-28 | 2017-08-29 | Trial Unspecified | 02 | N | 240032821 | TRIAL |
| 240011885 | 240008080 | 1.49 | 65.9 | Disease modification (D) | null | 2015-02-19 | Azacitidine | N | N | 240032838 | AZACITIDINE |
| 240011886 | 240012330 | 1.57 | 73.4 | Palliative (P) | 2016-09-19 | 2016-09-19 | Bevacizumab | 01 | N | 240032842 | BEVACIZUMAB |
| 240011887 | 240008083 | 1.66 | 111 | Palliative (P) | 2017-07-29 | 2017-08-25 | Carboplatin AUC 2 - 5 | 02 | N | 240032843 | CARBOPLATIN |
| 240011888 | 240012331 | null | 93.4 | null | 2018-01-29 | 2018-03-26 | Bevacizumab | 2 | N | 240032844 | BEVACIZUMAB |
| 240011889 | 240012331 | 1.68 | null | Curative (C) | 2014-08-08 | 2014-08-15 | ALCL ALCL 99 Closed AM 1, 2 or 3 | N | N | 240032844 | NOT MATCHED |
| 240011890 | 240012331 | 1.61 | 108 | Neo-adjuvant (N) | 2017-04-18 | 2017-04-25 | INTERLACE TRIAL | N | N | 240032844 | INTERLACE TRIAL |
| 240011891 | 240015854 | 1.56 | 125 | Palliative (P) | 2016-06-03 | 2016-09-17 | Trial Unspecified | N | null | 240032865 | TRIAL |
| 240011892 | 240008084 | 1.71 | 75 | Palliative (P) | 2017-05-25 | 2017-09-20 | Carboplatin AUC 2 - 5 | 02 | N | 240032870 | CARBOPLATIN |